Attana to present at the Redeye R&D Tools Seminar on November 10[th]
On Tuesday November 10th Redeye is hosting an online event and has invited five companies that provide tools & supplies for the biopharma industry and academia. Attana will begin its 15-minute presentation at 10.35 followed by a 5-minute Q&A session.
- Attana’s organizational development plans – presented by Niklas Carlsson, Attana’s newly appointed COO and Executive Vice President
- Attana patent application explained – Teodor Aastrup, CEO
- Vision Attana Diagnostics – Teodor Aastrup, CEO
Register for the seminar here
For more information, please contact:
Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in-vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org